{"record_id":"pl:presentation:89596","market_asked":null,"heading":"Related records in other markets","related_records_in_other_markets":[{"record_id":"be:presentation:cti:195072-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"195072-01","pack_level_published":true,"name":"NovoNorm 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["30"],"holder":"Novo Nordisk","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"1998-08-17","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"cu6UgJMkWF2JjQGXy-POLGCJBNhdTI21OZHuibcMY5svIO_6RqlwnHt7QMl_bmN5eZ8Gmeib_i0xjyWb4Symcg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/195072-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:195081-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"195081-01","pack_level_published":true,"name":"NovoNorm 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["90"],"holder":"Novo Nordisk","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"1998-08-17","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"y_Ihb6T0D_QtH9QFvDnjeRqsnRn_ixJi9PIx49IQY_9rQc86nMOGIkhFfnWJ1jVkal4UUf5ysexJcoYOgEYR9w","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/195081-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:195097-01","market":"BE","level":"presentation","gtin":"05712249109059","national_pack_code":null,"pack_level_published":true,"name":"NovoNorm 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["120"],"holder":"Novo Nordisk","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":true,"lifecycle":"current","period_from":"2024-01-01","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"UUFX2WbG9Mi9kW8NBuoH1hwEG29xw1Us2IjMITlBGNJFxRP4wIjqW1AG-gn287RxspG5oGMrc4mQABPXMf6i_A","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/05712249109059","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:224804-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"224804-01","pack_level_published":true,"name":"Prandin 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["30"],"holder":"Novo Nordisk","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2001-01-29","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"RpyoVWceK2Pmz5YNHnsDvKHfQFzbz-85Ju-PwUVWpvDCFs6k7WE6e66vexhpaYj8drKn8kCZ0O42YXIWfriCJg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/224804-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:224813-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"224813-01","pack_level_published":true,"name":"Prandin 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["90"],"holder":"Novo Nordisk","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2001-01-29","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"dV9hIWjqMBDjnZdWBR1paEgT9D7kY4yt8QBAZb8I5dY9JjjyMaHVRuVDP1f4SAqchYg1HitPEmkiiYs5j06euA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/224813-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:224822-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"224822-01","pack_level_published":true,"name":"Prandin 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["120"],"holder":"Novo Nordisk","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2001-01-29","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"26qMosgC8FH9L46uKil9YKNIJhsQ-G148AtTUfxaoSK5Cau2dHz4Gnx_K9UhBTcnCQ-GDkAKwlsfDOvL3sUILA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/224822-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:284383-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"284383-01","pack_level_published":true,"name":"Prandin 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["270"],"holder":"Novo Nordisk","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2006-05-22","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"vYNlJpcZgGGaGZNzBySukrr3mMxirj6u_GMHC5ZeCDC8QfCaG81TMHVouAX9PDEJH57B8jogL2lrjd2t1Bvy3A","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/284383-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:284444-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"284444-01","pack_level_published":true,"name":"NovoNorm 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["270"],"holder":"Novo Nordisk","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2006-05-29","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"Dic0j4YsZbJyEfHLV0HOvYsgQGwJdorMpQgzY3F6Ks9baL8jqoLAEXQUwY8TP2JhK-m_8j4gHE2YpBNRFBAYeg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/284444-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:346516-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"346516-01","pack_level_published":true,"name":"Repaglinide Teva 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["30"],"holder":"Teva Pharma","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-06-29","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"z5Nbv7JTBJpwDvTsYl2mi_E2TL4f8Ah0dKzRfrXXg12UGL185GRS_PjTafgoLZd__R3pBx6AiYLKq6QEad9XrA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/346516-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:346525-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"346525-01","pack_level_published":true,"name":"Repaglinide Teva 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["90"],"holder":"Teva Pharma","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-06-29","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"aFQ_9lgTlQzC9ByV6yaog6JbejX3A0PB06MqiJXJXPu90tEL89Th5Znn3KHif15b61_iycVCmqA6Ozb1b02vCg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/346525-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:346534-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"346534-01","pack_level_published":true,"name":"Repaglinide Teva 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["120"],"holder":"Teva Pharma","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-06-29","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"zQmtglVlmkqem3vXk16Flenz5da2E9uADR0MX888prmKc-HLs9N2AamsZ9_jc7LpoO3k2NJSmY_L-fmuzxUgFQ","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/346534-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:346543-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"346543-01","pack_level_published":true,"name":"Repaglinide Teva 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["270"],"holder":"Teva Pharma","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-06-29","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"9dUYTpTlPpwrWJSeEnrGTfO1KUS1_BJGYK9QsN38GMGpwjX_6AK9bpEaFRHdrN_-ll4w9C1C4xMm3XZ_myoW7g","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/346543-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:346552-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"346552-01","pack_level_published":true,"name":"Repaglinide Teva 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["360"],"holder":"Teva Pharma","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-06-29","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"cPMb1PHrYdBEWNFv_0czXAxgL0BXFiRHmEDL0rPh6cWeuxSclMZiUgMc-yXziF6vYuXZTUs-18FblhN5lU2-BA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/346552-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:355677-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"355677-01","pack_level_published":true,"name":"Repaglinide EG 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["15"],"holder":"EG","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-12-11","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"5WI__bhC-errMrM7e3um6JhIciw5hFUSNhj3_2QtHYIxcP-C7y2SkWfBVP_ukmG9zYWsppyK9X2QbQGF5qiLQA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/355677-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:355677-02","market":"BE","level":"presentation","gtin":null,"national_pack_code":"355677-02","pack_level_published":true,"name":"Repaglinide EG 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["30"],"holder":"EG","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-12-11","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"jYYZXUqxIuqsQOxYOdRqPxw8IVvTM145tvGRA0nsWvkbvxweyznQZxNb0z0c_fCgk3kj6Kh8cmBMEK4v-rsdew","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/355677-02","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:355677-03","market":"BE","level":"presentation","gtin":null,"national_pack_code":"355677-03","pack_level_published":true,"name":"Repaglinide EG 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["90"],"holder":"EG","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-12-11","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"IruIMbKK3CZ1BNNPRo9zGI8MGLST_JgSWmydTyqkAS7eKdleLPc7eS1lSrJ2_OtoHjJBipTgo4b66643-qyA9g","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/355677-03","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:355677-04","market":"BE","level":"presentation","gtin":null,"national_pack_code":"2720985","pack_level_published":true,"name":"Repaglinide EG 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["120"],"holder":"EG","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2019-03-16","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"0SX-jm8ScYjnr4n-x_QoK19htnXOMCzwCvcS3wskZDm-zLUroWfiF67aHz8QunJL6EfabkFWzRamf1ML_r6PXA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/2720985","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:355677-05","market":"BE","level":"presentation","gtin":null,"national_pack_code":"355677-05","pack_level_published":true,"name":"Repaglinide EG 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["180"],"holder":"EG","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-12-11","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"bfuRhSDpohp3GWVUG1Og8B21ICKbea4k-qkAtbKFclq4A8oDt5yDlUfy2NRyfLdEGanbHHmr7WX4aKMzgz6ZPA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/355677-05","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:355677-06","market":"BE","level":"presentation","gtin":"05400581005732","national_pack_code":null,"pack_level_published":true,"name":"Repaglinide EG 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["270"],"holder":"EG","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2025-09-09","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"E_yl6zzYksOg7_AwtIqb3gwxG2IMZWPZYZ-vKr32ir-GgUA89GOqYjqVWzk6sWxRKplKlfoWhw1mrT3zcDcC1A","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/05400581005732","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:356684-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"356684-01","pack_level_published":true,"name":"Repaglinide Sandoz 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["30"],"holder":"Sandoz","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2019-10-04","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"cB7heHhQrFG3yKCSdGYcFH5Ay1dL6fPeBsgfHlzb7a6oH4WLj_DGZXHjWFiAC1wRlY3_G5GGtKUwwpdtXEqlhQ","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/356684-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:356684-02","market":"BE","level":"presentation","gtin":null,"national_pack_code":"356684-02","pack_level_published":true,"name":"Repaglinide Sandoz 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["60"],"holder":"Sandoz","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2019-10-04","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"9cvKFIj_Isf7Pify-k73LWJZvTtqS7aArxZoya1W7_KUt9zD7CbAjVDZPPgq3fHCpt1phNN6ayzZV8OVJ7XdVg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/356684-02","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:356684-03","market":"BE","level":"presentation","gtin":null,"national_pack_code":"356684-03","pack_level_published":true,"name":"Repaglinide Sandoz 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["90"],"holder":"Sandoz","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2019-10-04","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"KgEkyU8F_AjTfO1R2hO5LkIT7oPrTyWkb_EaWsjTpew5Mpbvtdad392MAqBgV-Dpsgt73c_qnfnLhEl-Jb6HzQ","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/356684-03","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:356684-04","market":"BE","level":"presentation","gtin":null,"national_pack_code":"2753267","pack_level_published":true,"name":"Repaglinide Sandoz 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["120"],"holder":"Sandoz","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2019-10-04","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"nrL1R5Mhu8eRGDXD3jAm085aGAFM5ejM2NA6-I0Tg78fqtMn5RhzwSymC12_0uhNau09f_VvivDfQ2f8c_TJYA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/2753267","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:356684-05","market":"BE","level":"presentation","gtin":null,"national_pack_code":"2953131","pack_level_published":true,"name":"Repaglinide Sandoz 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["270"],"holder":"Sandoz","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2020-03-01","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"ts416R5sGtejQ8r9gOnI2Pc5KLFztUkmSDqQUOiQn-M5Dna9dBHnTqWjBB-kQSg3CjjCPqoABxeeaJNdcFn3WQ","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/2953131","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:356693-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"356693-01","pack_level_published":true,"name":"Repaglinide Sandoz 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["30"],"holder":"Sandoz","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2019-10-04","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"1IDu195db1oH_oxEcsBXlpovy8MzrAzDXASA3X7Z_YNYmX6Z8a0uLI4FYNN-yyfn8_AXqxaNMgZECHPo5baXgQ","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/356693-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:356693-02","market":"BE","level":"presentation","gtin":null,"national_pack_code":"356693-02","pack_level_published":true,"name":"Repaglinide Sandoz 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["60"],"holder":"Sandoz","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2019-10-04","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"Olv29M6YoDufLFkBwAH9EJCdm0tEAZZrA7rJOBe7Ub2ro1Q0D4Tfw8bf-CXTzr7j8WQ3XPnHHBwE_BJWCMayZA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/356693-02","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:356693-03","market":"BE","level":"presentation","gtin":null,"national_pack_code":"356693-03","pack_level_published":true,"name":"Repaglinide Sandoz 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["90"],"holder":"Sandoz","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2019-10-04","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"bIdt9Y1iNwGSZNPg9tTFA99no89xXvQdjIEH5VbJRKB-2ztD6V_pa0CoYhYFkLgKvptfzXMYE-7ua2rF-oClPg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/356693-03","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:356693-04","market":"BE","level":"presentation","gtin":null,"national_pack_code":"356693-04","pack_level_published":true,"name":"Repaglinide Sandoz 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["250"],"holder":"Sandoz","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2019-10-04","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"JQ6JGmPb08MlcSHC9b3KN8TBHnjFFspPwPTa-tfRQjssfYN1XXmZnNTJqFx0eNrxqTmK_jRD5yaKGkX4kbG-cg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/356693-04","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:358163-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"358163-01","pack_level_published":true,"name":"Repaglinide Krka 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["30"],"holder":"KRKA d.d. Novo mesto","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-11-04","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"Ikpesx21tNev-sTNnD3Kreocpw8kJG6gxN9Atqzc2k_nOcYaan7doQ17mMsILtsy8_PKD3DTN2pLIPXSVTIusA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/358163-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:358172-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"358172-01","pack_level_published":true,"name":"Repaglinide Krka 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["60"],"holder":"KRKA d.d. Novo mesto","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-11-04","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"K-btHzGCZgioqfHW1boqysVUECCts2oSovH8CcQZW-HwyhsUYc2KCVubXJeqJWQlL1IkarIfw5B4Bp8M0SMB_Q","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/358172-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:358181-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"358181-01","pack_level_published":true,"name":"Repaglinide Krka 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["90"],"holder":"KRKA d.d. Novo mesto","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-11-04","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"fOXtLMMIrjrxIbUpQpWPiMVt_31EA9ldVEYmKO1W1mc8GDEk3MubXUsQ35pvpo3Lfz888VRKNHpSnL3phQSyYA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/358181-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:358197-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"358197-01","pack_level_published":true,"name":"Repaglinide Krka 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["120"],"holder":"KRKA d.d. Novo mesto","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-11-04","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"1Ep6jHggKD_zYQ9T96A8hUFy8Kdg2XtOyWltLCDl2usEBTmJphiM1PDXrAHPjNr6pWmlko9g5nmxMn0JtMJjiQ","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/358197-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:358206-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"358206-01","pack_level_published":true,"name":"Repaglinide Krka 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["270"],"holder":"KRKA d.d. Novo mesto","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-11-04","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"A9lD6RQwVA0k6glspVQPa-OiJfNT5UfG-s5wqufq7SbkQ-Yb5hK-pOPDPPJ2LPy_ZWWwK0LwkSydcyuZnGNoFg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/358206-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:358215-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"358215-01","pack_level_published":true,"name":"Repaglinide Krka 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["360"],"holder":"KRKA d.d. Novo mesto","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-11-04","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"5eMw-o8r26YOatPeguJgbmoiz5UzqqX4LOzUr1shmRXWdfz01FDM88KJW7sfvidy1-WoKNlS1YcdIBfTwVpZbw","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/358215-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:358346-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"358346-01","pack_level_published":true,"name":"Enyglid 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["30"],"holder":"KRKA d.d. Novo mesto","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-10-14","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"7C_DtiTQ5lDU9pTk9E_aBWys5FTCu1iJ_8Jo8iDrb8EAfuv_FK9QPheQMM7XgMJDVilfIWrtV03_vA5xY9bBXA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/358346-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:358461-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"358461-01","pack_level_published":true,"name":"Enyglid 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["60"],"holder":"KRKA d.d. Novo mesto","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-10-14","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"f9iUOTNOGc_TCZIor0mAXEGaLUJBJANkWRZ8MMzHFNYTla9nDYiOm8eEqqRX_UiYxbPhL9rjhu93xxTQdDYmOw","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/358461-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:358477-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"358477-01","pack_level_published":true,"name":"Enyglid 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["90"],"holder":"KRKA d.d. Novo mesto","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-10-14","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"TA-aEtfIyrjIcd2iz7PH2hYbeRIN079djOwEMGWkpNv61fYDbQy1yNFg_HhLXvQ1kc3X3CBUk-7c9dGbg9V-SA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/358477-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:358486-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"358486-01","pack_level_published":true,"name":"Enyglid 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["120"],"holder":"KRKA d.d. Novo mesto","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-10-14","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"84oCRnySLOHOJEdlRJfuxxmA_fhWf8fvWhkD65kcPCwACiCj9i7RSbTIbWrUYWj5ATVM9LHWHcz0BaaxPkllfw","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/358486-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:358495-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"358495-01","pack_level_published":true,"name":"Enyglid 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["270"],"holder":"KRKA d.d. Novo mesto","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-10-14","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"zPImz011kBn_MofPuND6RnxvGUsxz0YWg-DSNUYYJ_g0CdADiZuiiAX9uE2PyH64W1fNNUkKTsJVZrvZlijlww","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/358495-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:358601-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"358601-01","pack_level_published":true,"name":"Enyglid 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["360"],"holder":"KRKA d.d. Novo mesto","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2009-10-14","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"4PUPiadiA27q7IZXKULuHB6Jks7qbqskOIOE5Oa7xxHn71vTJUoOrB6M5FrBacfJJT6CpGYZyprJpN7K3KOblg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/358601-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:378594-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"378594-01","pack_level_published":true,"name":"Repaglinide Mylan 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["30"],"holder":"Viatris GX","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2022-09-01","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"7-ME_vnFu9XD-OQ9YofPdDbJmm3-FXeib4MqpuKL1Hxqs_sXFOIML5YveBFdE1eh8lPrjhXvUxIqMaatPDNFuw","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/378594-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:378594-02","market":"BE","level":"presentation","gtin":null,"national_pack_code":"378594-02","pack_level_published":true,"name":"Repaglinide Mylan 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["90"],"holder":"Viatris GX","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2022-09-01","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"LfDRgUeWwN3mksLXQDfCmLfVFnVTW4TobeHngpDgW2Oe3gP8Ai7Xs8lxGtUYjYU4AiuX_y1ZvC_nf_4NKe0neA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/378594-02","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:378594-03","market":"BE","level":"presentation","gtin":null,"national_pack_code":"2793883","pack_level_published":true,"name":"Repaglinide Mylan 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["120"],"holder":"Viatris GX","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2022-09-01","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"sTXlvQxgBI8p0VxopbiRs9V7MewS3K-TUhOS8XRkfRqpH_Cjcvw4srUED-N2Cd4l810pWzre04Ys5Lul2Unm-A","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/2793883","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:378594-04","market":"BE","level":"presentation","gtin":null,"national_pack_code":"2804300","pack_level_published":true,"name":"Repaglinide Mylan 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["200"],"holder":"Viatris GX","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2022-09-01","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"lQLvv02lLE1l4-OpnuH45vBswKma1u0La6M7xdiiESVomkKNe54lJvMOUsYEdSZgbiiAfqOXMVnldoWqpM9uYw","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/2804300","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:378594-05","market":"BE","level":"presentation","gtin":null,"national_pack_code":"378594-05","pack_level_published":true,"name":"Repaglinide Mylan 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["270"],"holder":"Viatris GX","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2022-09-01","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"iPurwVa9WqXtHr-urXgB1OJHQHFFgg5LmkGMqTlhrYDi0a9lwIoRBszTDqMURP5Zzpl4v2xn3sy8IhyHmEA4Ww","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/378594-05","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:378603-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"378603-01","pack_level_published":true,"name":"Repaglinide Mylan 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["100"],"holder":"Viatris GX","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2022-09-01","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"n1hVVUNHwAp6C1l-3Im5SSSRE_-Siue9UrmC71knZkkKVFo8uW2znOOp8imU8I2r0-Na6MnhZCYnbE17nvL4Jw","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/378603-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:386626-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"386626-01","pack_level_published":true,"name":"Enyglid 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["180"],"holder":"KRKA d.d. Novo mesto","status":{"state":"current","value":{"amp_status":"AUTHORIZED","ampp_status":"AUTHORIZED","commercialised_now":false,"lifecycle":"current","period_from":"2010-11-03","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"kkgSUOcw0eJpqYTpN8cJkvp4YMDUVsyyKLTpf5YmKLaeeVT4NRvMPagQRkYIvYeped_eiv3EEIs-6Je-RvbXAg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/386626-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:412806-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"412806-01","pack_level_published":true,"name":"Repaglinide Accord 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["30"],"holder":"Accord Healthcare","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2026-07-29","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"fybluDoFDZLYf_ApR6i_rMhe3vSmydLxBoj9yH4JyP38stfuz2P6198IbXgUM5I6imE9a29MB3Kbn8jOcNia3g","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/412806-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:412815-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"412815-01","pack_level_published":true,"name":"Repaglinide Accord 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["90"],"holder":"Accord Healthcare","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2026-07-29","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"NkRumLBAmCjjyUotvK-ALrQiQyX6hgBSHRGWifrg5-2YbzPf8-lo5C9LntxU8IioB7Kzqmd5eq1PlJPaGY-pXA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/412815-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:412824-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"7715295","pack_level_published":true,"name":"Repaglinide Accord 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["120"],"holder":"Accord Healthcare","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2026-07-29","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"fkKcGN59IvuE8lzr60FZmii8RkOTQabSOpTSeZTXckS2MLULUmz_5d5fCdzsVTwKXOPjfb0JkS6ZRjR795L5xw","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/7715295","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:412833-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"7715295","pack_level_published":true,"name":"Repaglinide Accord 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["270"],"holder":"Accord Healthcare","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2026-07-29","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"mHCgCu2n87wd3zI-M2pXpPOaDtwcV6CJYQOgqdbx2O8yBMmvGr4Z264XSckGZ6zZQU9AsDGLQ1kDlV5eljYtjQ","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/7715295","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:412842-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"412842-01","pack_level_published":true,"name":"Repaglinide Accord 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["100"],"holder":"Accord Healthcare","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2026-07-29","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"LlZ_gDktUU6a8hNCeyWj9cpBBJiQCCTYfbuwqn0NJEOjDD8qKrQ6kCocLvQy9cBb92eHXuMG0-_mSyFVckygHg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/412842-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:422484-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"422484-01","pack_level_published":true,"name":"Repaglinide Mylan Pharma 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["30"],"holder":"Viatris GX","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2012-06-15","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"F8VjhG3lTo9xAbuxz2ES_k5n7hrUmPE2EoIqP4-5owZ_oLN54sUj1muMIS4V2BHDUg4EO_Qi33z9255I4cbUBg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/422484-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:422484-02","market":"BE","level":"presentation","gtin":null,"national_pack_code":"422484-02","pack_level_published":true,"name":"Repaglinide Mylan Pharma 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["90"],"holder":"Viatris GX","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2012-06-15","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"JhefTAIB8N5uEXkrSNI8BiuF-WQaC4PDW9xeMeb67cWwKvtbezLZNh-mQEs8t8zXJAW-3dtDtVPAgKMHUBqi8w","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/422484-02","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:422484-03","market":"BE","level":"presentation","gtin":null,"national_pack_code":"422484-03","pack_level_published":true,"name":"Repaglinide Mylan Pharma 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["120"],"holder":"Viatris GX","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2012-06-15","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"2Hw0VU3O4XVDYzNcW7F3dnme3DT_xubeRPEV7Gb-6Nk8TW3B83qZAhnkL1uOMO-Bo2GiCFR1B6isJpISHbGk1w","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/422484-03","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:422484-04","market":"BE","level":"presentation","gtin":null,"national_pack_code":"422484-04","pack_level_published":true,"name":"Repaglinide Mylan Pharma 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["180"],"holder":"Viatris GX","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2012-06-15","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"X9NHWkImIMqDJWFx8KQRNo29ki9TI1YSXA63LsiXy9yLchPuhOkFjMU4eiRZq0Gi7qrUL7ugSG2E9671iBSEng","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/422484-04","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:422484-05","market":"BE","level":"presentation","gtin":null,"national_pack_code":"422484-05","pack_level_published":true,"name":"Repaglinide Mylan Pharma 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["200"],"holder":"Viatris GX","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2012-06-15","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"4Mri9Sk32H62socg9G0koLCuoYQDC-DuQJuWyprc5OOtj-GE2JHUKstroFzCNjbY8V3tw9dQQ_FEp_AngeklNg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/422484-05","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:422484-06","market":"BE","level":"presentation","gtin":null,"national_pack_code":"422484-06","pack_level_published":true,"name":"Repaglinide Mylan Pharma 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["270"],"holder":"Viatris GX","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2012-06-15","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"edDnYY6IkWeJLcZDYjMPKPwf6fT26-9EovgNWNtrb-PNRLB9JoWQioeUYZFpfk0fA3V3dI54yUwJza5SGmkktw","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/422484-06","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:422493-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"422493-01","pack_level_published":true,"name":"Repaglinide Mylan Pharma 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["120"],"holder":"Viatris GX","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2012-06-15","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"ycF86hcryLcJtLt75xvAQWUMQu6nSoI_kTrJTZUGRj0OB8-Z_AmOpNPfTfNZzO3jCMFiv5BDDRT0OMGx-VOgdg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/422493-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:422493-02","market":"BE","level":"presentation","gtin":null,"national_pack_code":"422493-02","pack_level_published":true,"name":"Repaglinide Mylan Pharma 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["200"],"holder":"Viatris GX","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2012-06-15","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"46Vo_qPlouacanUIKvLGRxSGz5rMYUWM8gQ4fxVJwQuHafOgkS6lewxwDGf2Jed2xQU4IhKE86s5SktEsQ48AA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/422493-02","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:422493-03","market":"BE","level":"presentation","gtin":null,"national_pack_code":"422493-03","pack_level_published":true,"name":"Repaglinide Mylan Pharma 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["270"],"holder":"Viatris GX","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2012-06-15","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"s9sLWU8MiSljOjhrKjm9bJJm1vAal-xua0s3RE_uqbNOdvZh0Sy91N2Gj7m_vXng6EGFX89BnUVcglFT9mtaFA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/422493-03","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"be:presentation:cti:494951-01","market":"BE","level":"presentation","gtin":null,"national_pack_code":"494951-01","pack_level_published":true,"name":"Repaglinide Accord 1 mg","substance":["Repaglinide"],"strength":["1.0000 mg"],"form":["Tablet"],"pack":["180"],"holder":"Accord Healthcare","status":{"state":"current","value":{"amp_status":"REVOKED","ampp_status":"REVOKED","commercialised_now":false,"lifecycle":"history","period_from":"2026-07-29","period_to":null,"supply_problem_now":false}},"source_authority":"FAMHP","read_at":"2026-11-15T03:58:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"znjBfkkPAiXsApII9gi79BEP1v2_5NH20jirUuwVynKHlML6jfKSe5kWgs0GRitgGoRBd7PEMU6nbBUEAP3-9A","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/be/494951-01","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"bg:presentation:pack:BG/20090545/001","market":"BG","level":"presentation","gtin":null,"national_pack_code":"BG/20090545/001","pack_level_published":true,"name":"INDORIN","substance":["Repaglinide"],"strength":["1 mg tablets"],"form":["tablets"],"pack":["15"],"holder":"Stada Arzneimittel AG","status":{"state":"current","value":{"in_register":true,"lifecycle":"current"}},"source_authority":"ИАЛ","read_at":"2026-11-15T04:02:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"nAzPjPZZvZNeTcek0AdKwPSmzhcwIpmG4QxlvjoakfYCVbwtAi4YnPjwIWIAq7PBODuBp60N2gSLoKHYPb4l3A","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/bg/BG/20090545/001","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"bg:presentation:pack:BG/20090545/002","market":"BG","level":"presentation","gtin":null,"national_pack_code":"BG/20090545/002","pack_level_published":true,"name":"INDORIN","substance":["Repaglinide"],"strength":["1 mg tablets"],"form":["tablets"],"pack":["30"],"holder":"Stada Arzneimittel AG","status":{"state":"current","value":{"in_register":true,"lifecycle":"current"}},"source_authority":"ИАЛ","read_at":"2026-11-15T04:02:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"jROrRTN_6XU4NXluhyw1l0sm9jGyA8gIHVPDOufCHJp1On-y4QjOnqRugR8ODT8S3L1MOY67Qdx4CCvyKUjmvQ","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/bg/BG/20090545/002","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"bg:presentation:pack:BG/20090545/003","market":"BG","level":"presentation","gtin":null,"national_pack_code":"BG/20090545/003","pack_level_published":true,"name":"INDORIN","substance":["Repaglinide"],"strength":["1 mg tablets"],"form":["tablets"],"pack":["90"],"holder":"Stada Arzneimittel AG","status":{"state":"current","value":{"in_register":true,"lifecycle":"current"}},"source_authority":"ИАЛ","read_at":"2026-11-15T04:02:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"LOCR3M9qYomgF_vg9UUp1TGCtr8zQSqTs9fbZEcLi9bd7Gb0hAm5Ta2nEEmUWiizEi0xC_8dNpIeFbQAksrrsQ","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/bg/BG/20090545/003","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"bg:presentation:pack:BG/20090545/004","market":"BG","level":"presentation","gtin":null,"national_pack_code":"BG/20090545/004","pack_level_published":true,"name":"INDORIN","substance":["Repaglinide"],"strength":["1 mg tablets"],"form":["tablets"],"pack":["120"],"holder":"Stada Arzneimittel AG","status":{"state":"current","value":{"in_register":true,"lifecycle":"current"}},"source_authority":"ИАЛ","read_at":"2026-11-15T04:02:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"PuyDeP0neiPQeiz0HOhmJz80FWUN0hkSDyNv6KAZ5qXNB-mDFfZ9bGqZC2ECclWU47KJs7eXc4n4JqeuU1Bzig","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/bg/BG/20090545/004","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"bg:presentation:pack:BG/20090545/005","market":"BG","level":"presentation","gtin":null,"national_pack_code":"BG/20090545/005","pack_level_published":true,"name":"INDORIN","substance":["Repaglinide"],"strength":["1 mg tablets"],"form":["tablets"],"pack":["180"],"holder":"Stada Arzneimittel AG","status":{"state":"current","value":{"in_register":true,"lifecycle":"current"}},"source_authority":"ИАЛ","read_at":"2026-11-15T04:02:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"37hec3SXVrXYcF7JJ8aYJsoLFe5qXG1hx7Qb9_MS_WLFz04KkDZV4RFZp0NrK4d_jQOjdW0510WwvQU4Ucjd5Q","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/bg/BG/20090545/005","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"bg:presentation:pack:BG/20090545/006","market":"BG","level":"presentation","gtin":null,"national_pack_code":"BG/20090545/006","pack_level_published":true,"name":"INDORIN","substance":["Repaglinide"],"strength":["1 mg tablets"],"form":["tablets"],"pack":["270"],"holder":"Stada Arzneimittel AG","status":{"state":"current","value":{"in_register":true,"lifecycle":"current"}},"source_authority":"ИАЛ","read_at":"2026-11-15T04:02:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"x4iJWGY_CJ3D0whPdabpsKeM9Hlq7SZrOqKDxhPsEOGGN0K68aZzLSgW_aRue7_V3dN4dRms9wN1N38sxkT9Vg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/bg/BG/20090545/006","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"bg:presentation:pack:BG/20100120/001","market":"BG","level":"presentation","gtin":null,"national_pack_code":"BG/20100120/001","pack_level_published":true,"name":"Neoglinid","substance":["Repaglinide"],"strength":["1 mg tablets"],"form":["tablets"],"pack":["90"],"holder":"Нео Балканика ЕООД","status":{"state":"current","value":{"in_register":true,"lifecycle":"current"}},"source_authority":"ИАЛ","read_at":"2026-11-15T04:02:09Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"Fs-h8Bs09xz_tPX6v5c8lRsZ1wXPRB5lJnGPwvV1vYx3URNHnlLe_Le0J7hsapybxyco-FS--SkbrYTEfqXoKg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/bg/BG/20100120/001","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"ch:presentation:61234-017","market":"CH","level":"presentation","gtin":"07680612340171","national_pack_code":null,"pack_level_published":true,"name":"Repaglinide Rivopharm, compresse","substance":["repaglinidum"],"strength":["Repaglinide Rivopharm 1 mg, compresse","1 MG"],"form":["TAB"],"pack":["90"],"holder":"Rivopharm SA","status":{"state":"current","value":{"first_authorisation":"2011-05-24","term":"zugelassen","valid_until":"9999-12-31"}},"source_authority":"Swissmedic","read_at":"2026-11-15T01:25:13Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"-eES1e5GLsEpvLtauJlGJuw7pasrZpMpSUoXY0Sw7nkLIuZPaxlVFUM4LYzSFxG9iil6XsF0rfUDyhzXe9Zpgw","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/ch/07680612340171","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"dk:presentation:varenr:039168","market":"DK","level":"presentation","gtin":"07046260391680","national_pack_code":null,"pack_level_published":true,"name":"Repaglinide \"Krka\"","substance":["Repaglinid"],"strength":["1 mg"],"form":["tabletter"],"pack":["90 stk. (blister)"],"holder":"Krka AB","status":{"state":"current","value":{"left_list_on":null,"lifecycle":"current","on_price_list":true}},"source_authority":"Lægemiddelstyrelsen","read_at":"2026-11-15T06:55:20Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"7BQZ8EMD5DBuPd8BKg4Ny4Wz3TVe7Ic0jgSJ1IwoCp3ueQb5Gy6BXegPN3d7xXascxkJmTmMRTOliEejj77YYQ","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/dk/07046260391680","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"dk:presentation:varenr:090151","market":"DK","level":"presentation","gtin":"07046260901513","national_pack_code":null,"pack_level_published":true,"name":"Repaglinide \"Accord\"","substance":["Repaglinid"],"strength":["1 mg"],"form":["tabletter"],"pack":["90 stk. (blister)"],"holder":"Accord Healthcare","status":{"state":"current","value":{"left_list_on":"2026-08-31","lifecycle":"history","on_price_list":false}},"source_authority":"Lægemiddelstyrelsen","read_at":"2026-11-15T06:55:20Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"X66KbLs1osZOR-5dUaGYP6R5kHGD3aPKyRmw4ACnwFF_Uo2vBcG4zbdtqkctSLPPg7XPjOkj8w29XDVLfU3TEw","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/dk/07046260901513","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"dk:presentation:varenr:396285","market":"DK","level":"presentation","gtin":"07046263962856","national_pack_code":null,"pack_level_published":true,"name":"NovoNorm","substance":["Repaglinid"],"strength":["1 mg"],"form":["tabletter"],"pack":["90 stk. (blister) (2care4)"],"holder":"2care4","status":{"state":"current","value":{"left_list_on":"2025-04-14","lifecycle":"history","on_price_list":false}},"source_authority":"Lægemiddelstyrelsen","read_at":"2026-11-15T06:55:20Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"gLYP9-FgVUswa6E76mcfgzNcYlnJAPZCPhMHKMQMHXc0BZ_kX5WvaUc9SwCWyra4_Kcd1aQCXu1I6Ua4QXp3Lw","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/dk/07046263962856","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"dk:presentation:varenr:517755","market":"DK","level":"presentation","gtin":"07046265177555","national_pack_code":null,"pack_level_published":true,"name":"NovoNorm","substance":["Repaglinid"],"strength":["1 mg"],"form":["tabletter"],"pack":["90 stk. (blister)"],"holder":"Novo","status":{"state":"current","value":{"left_list_on":"2025-05-26","lifecycle":"history","on_price_list":false}},"source_authority":"Lægemiddelstyrelsen","read_at":"2026-11-15T06:55:20Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"JX2GZKVRD04SA-CsYxYN4VWr_ULhBzJR2RmAa1teDYEsIavK-eEZjLjzIMRY1WF__iRhq0gCna2eQHTLFCjJrA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/dk/07046265177555","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:650664","market":"ES","level":"presentation","gtin":"08470006506646","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDA SANDOZ 1 mg COMPRIMIDOS EFG , 90 comprimidos","substance":["REPAGLINIDA"],"strength":["1 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"SANDOZ FARMACEUTICA S.A.","status":{"state":"current","value":{"lifecycle":"current","marketed":true,"marketing_date":"2024-06-14","pack_status":"Autorizado","pack_status_date":"2011-08-18"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"VqOFiq-o9N7P87wRkkSqSIgW97OLDHaxJoZTKtPvlJxrFWw2G1A3VGjvaSz-0c0OQqe_NGU457AE8olh3kpJUw","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08470006506646","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:651159","market":"ES","level":"presentation","gtin":"08470006511596","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDA CINFA 1 mg COMPRIMIDOS EFG , 90 comprimidos","substance":["REPAGLINIDA"],"strength":["1 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"LABORATORIOS CINFA S.A.","status":{"state":"current","value":{"lifecycle":"current","marketed":false,"marketing_date":"2011-10-24","pack_status":"Suspenso","pack_status_date":"2024-04-02"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"ojUGfxteL59JZyiagQbg9ahg6I2txq4LjOXk1ZR2ihaQn0YG8RUBcRSSzihvxuSv36HjmACD8PF8dO3YwuQGaw","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08470006511596","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:652561","market":"ES","level":"presentation","gtin":"08470006525616","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDA AUROVITAS SPAIN 1 mg COMPRIMIDOS EFG , 90 comprimidos","substance":["REPAGLINIDA"],"strength":["1 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"AUROVITAS SPAIN, S.A.U.","status":{"state":"current","value":{"lifecycle":"history","marketed":false,"marketing_date":"2021-11-15","pack_status":"Anulado","pack_status_date":"2021-11-15"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"mIZAfjINwkJXNeODwOLHWMmmLu2HJ_BbQPO1hJwudax6f7gL3RNK3Xbt9TIiAC6u6hKxNeMtgtcTMfqQtkw7Lg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08470006525616","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:672341","market":"ES","level":"presentation","gtin":"08435232347562","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDA NORMON 1 mg COMPRIMIDOS EFG, 90 comprimidos","substance":["REPAGLINIDA"],"strength":["1 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"LABORATORIOS NORMON S.A.","status":{"state":"current","value":{"lifecycle":"current","marketed":true,"marketing_date":"2011-05-12","pack_status":"Autorizado","pack_status_date":"2010-08-31"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"BUviCzFwbg5K2drPZLKNaCnLB1YRODjgoozalq-kcWnKMjnTSJ9a8zirnhGpYjFf9rSHVC1zySlGVpgZKpuzDw","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08435232347562","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:673013","market":"ES","level":"presentation","gtin":"08470006730133","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDA RATIOPHARM 1 mg COMPRIMIDOS EFG, 90 comprimidos","substance":["REPAGLINIDA"],"strength":["1 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"RATIOPHARM ESPANA S.A.","status":{"state":"current","value":{"lifecycle":"history","marketed":false,"marketing_date":"2021-02-24","pack_status":"Anulado","pack_status_date":"2021-02-24"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"7sWBYWEDFkhs8FnmrloPyPuXDfn4DmSfBzKaWDrL8EgIlKth-MxsuM5CokcLh1jlqzeFm-apx29WH2vC_kHV9w","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08470006730133","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:673901","market":"ES","level":"presentation","gtin":"08470006739013","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDA STADA 1 mg COMPRIMIDOS EFG, 90 comprimidos","substance":["REPAGLINIDA"],"strength":["1 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"LABORATORIO STADA S.L.","status":{"state":"current","value":{"lifecycle":"current","marketed":true,"marketing_date":"2011-06-20","pack_status":"Autorizado","pack_status_date":"2011-03-25"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"rMGvAEDVf1Kq9Nc02PZa5uWUYWf7NIXfsLMwflzJGZBlZ4lmvCGeHpOmI933gmzgVOTQ5AMjgyadsBng2yqeOg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08470006739013","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:675154","market":"ES","level":"presentation","gtin":"08470006751541","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDA APOTEX 1 mg COMPRIMIDOS EFG , 90 comprimidos","substance":["REPAGLINIDA"],"strength":["1 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"APOTEX EUROPE B.V.","status":{"state":"current","value":{"lifecycle":"history","marketed":false,"marketing_date":"2021-01-21","pack_status":"Anulado","pack_status_date":"2021-01-21"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"X7WVpK-CZXX2MwgwnXTmK8d6WFPyeOTII0vFbHbtD-Kj-ijWMBY4rK9jONV4rtpJpAl0KIl5hBKMeFdPcZzAMg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08470006751541","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:676241","market":"ES","level":"presentation","gtin":"08470006762417","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDA VIATRIS 1 MG COMPRIMIDOS EFG, 90 comprimidos","substance":["REPAGLINIDA"],"strength":["1 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"VIATRIS LIMITED","status":{"state":"current","value":{"lifecycle":"current","marketed":true,"marketing_date":"2011-09-21","pack_status":"Autorizado","pack_status_date":"2011-04-14"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"-RNyAdzkDffDtrBhPnCxUSEWHA6vXR4N9H4wrNFD1CHSVK-aix7Oj7zts1z4Esljxi17ngTjDQaaMwAHNy5hZA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08470006762417","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:677570","market":"ES","level":"presentation","gtin":"08470006775707","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDA ALTER 1 mg COMPRIMIDOS EFG, 90 comprimidos","substance":["REPAGLINIDA"],"strength":["1 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"LABORATORIOS ALTER S.A.","status":{"state":"current","value":{"lifecycle":"current","marketed":true,"marketing_date":"2011-07-07","pack_status":"Autorizado","pack_status_date":"2011-02-28"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"s19Irz61vSXJttAUm3TxYMifnME7pZZacolMbfQsAEkQpXjXv3Bpck0SPtPOy5T-YmLAF-N00jCL8yR0jRC8og","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08470006775707","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:677667","market":"ES","level":"presentation","gtin":"08470006776674","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDA TEVA 1 mg COMPRIMIDOS EFG, 90 comprimidos","substance":["REPAGLINIDA"],"strength":["1 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"TEVA B.V.","status":{"state":"current","value":{"lifecycle":"current","marketed":false,"marketing_date":"2023-07-27","pack_status":"Autorizado","pack_status_date":"2011-04-13"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"B3Tm6qWJfPOyXiGI5KAi5UYfo7eSjVj6479o1iS_LERdWIsZ66m69MJvyjqYSHOLPJlRkk66sUHCe_JpQlkulA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08470006776674","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:680383","market":"ES","level":"presentation","gtin":"08470006803837","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDA TARBIS 1 MG  COMPRIMIDOS EFG , 90 comprimidos","substance":["REPAGLINIDA"],"strength":["1 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"TARBIS FARMA S.L.","status":{"state":"current","value":{"lifecycle":"current","marketed":false,"marketing_date":"2014-09-10","pack_status":"Autorizado","pack_status_date":"2011-05-13"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"97tGn9mxTRVID0tLJFWAng89nPaYCQIWTreEjRiO9BjCBmwsPbDZYOVLyXBuc51rx38WeFSWL6_J6l65uqLQOQ","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08470006803837","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:680755","market":"ES","level":"presentation","gtin":"08470006807552","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDA COMBIX 1 mg COMPRIMIDOS  EFG, 90 comprimidos","substance":["REPAGLINIDA"],"strength":["1 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"LABORATORIOS COMBIX S.L.U.","status":{"state":"current","value":{"lifecycle":"current","marketed":true,"marketing_date":"2011-10-24","pack_status":"Autorizado","pack_status_date":"2011-05-20"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"FTv0YpbijXqtNCTOGTZAZdoIWSQ4P6tQe102ggoP9sCI8AAy_k58FXs7NXKgl_24VotDOclJyuVU80OuUTHBNw","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08470006807552","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:680773","market":"ES","level":"presentation","gtin":"08436531244972","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDA KERN PHARMA 1 mg COMPRIMIDOS EFG, 90 comprimidos","substance":["REPAGLINIDA"],"strength":["1 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"KERN PHARMA S.L.","status":{"state":"current","value":{"lifecycle":"current","marketed":true,"marketing_date":"2011-08-31","pack_status":"Autorizado","pack_status_date":"2011-05-24"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"0Yhs8N5KVCQjEOBhdy3WxieTU108FVSVpz0F10aOxnoswFfRFfM06Rea6iPj5Soer80wgCgHDNirz-8Pmhue1w","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08436531244972","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:680787","market":"ES","level":"presentation","gtin":"08436577301721","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDA PENSA 1 mg COMPRIMIDOS EFG , 90 comprimidos","substance":["REPAGLINIDA"],"strength":["1 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"TOWA PHARMACEUTICAL S.A.","status":{"state":"current","value":{"lifecycle":"current","marketed":true,"marketing_date":"2013-03-04","pack_status":"Autorizado","pack_status_date":"2011-05-24"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"A3xDKWFG_6B_Cer0_tDF3nZ-UqtrQmdshxBFijEof0tCn_1SI6FufFKZJrBCa15QMNypalDr9Bo2lTG5nZ-TFA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08436577301721","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:683796","market":"ES","level":"presentation","gtin":"08470006837962","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDA EDIGEN 1 mg COMPRIMIDOS EFG , 90 comprimidos","substance":["REPAGLINIDA"],"strength":["1 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"ARISTO PHARMA IBERIA S.L.","status":{"state":"current","value":{"lifecycle":"history","marketed":false,"marketing_date":"2020-08-06","pack_status":"Anulado","pack_status_date":"2020-08-06"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"qCATerD0Y4n6psG2h1_U_tsubpqdXqmQ8A2BcyI-IS_qQ5f308FVzsiZIVid1Hqgcd-38J6IyUO0xVDKl1Lrpw","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08470006837962","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:694095","market":"ES","level":"presentation","gtin":"08470006940952","national_pack_code":null,"pack_level_published":true,"name":"Enyglid 1 mg comprimidos EFG, 90 comprimidos","substance":["REPAGLINIDA"],"strength":["1 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"KRKA D.D. NOVO MESTO","status":{"state":"current","value":{"lifecycle":"current","marketed":false,"marketing_date":"2019-04-22","pack_status":"Autorizado","pack_status_date":"2012-10-25"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"qWzrU4lwzln7X3vROyYGz94LXY1_iGm97SZducF_NhB0pt8MaCbBjVne6mu8mPIS9Yo868gxwgX8sOcRaZkVQA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08470006940952","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:694335","market":"ES","level":"presentation","gtin":"08470006943359","national_pack_code":null,"pack_level_published":true,"name":"Repaglinida Accord 1 mg comprimidos EFG, 90 comprimidos","substance":["REPAGLINIDA"],"strength":["1 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"ACCORD HEALTHCARE S.L.U.","status":{"state":"current","value":{"lifecycle":"history","marketed":false,"marketing_date":"2026-08-28","pack_status":"Anulado","pack_status_date":"2026-08-28"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"rVP_R6CJLFkgDdiMR3EwY2GmxoOl1rwXx05l7SuJTiNKC4MslQsJEhaz-mpskuvQ5KRcampoYlMwjrzmF1_DQg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08470006943359","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:695745","market":"ES","level":"presentation","gtin":"08470006957455","national_pack_code":null,"pack_level_published":true,"name":"Repaglinida Krka 1 mg comprimidos EFG, 90 comprimidos","substance":["REPAGLINIDA"],"strength":["1 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"KRKA D.D. NOVO MESTO","status":{"state":"current","value":{"lifecycle":"current","marketed":true,"marketing_date":"2020-07-10","pack_status":"Autorizado","pack_status_date":"2012-12-21"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"xdGZV5skg7W30MxpKdThmxsv27obOlz7BtHyu96T_GAOQ1hE09Bd1i44lOPI0wrKxDPipkSOCtvfxr_zn1C50w","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08470006957455","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:696165","market":"ES","level":"presentation","gtin":"08470006961650","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDA AUROBINDO 1 MG COMPRIMIDOS EFG , 90 comprimidos","substance":["REPAGLINIDA"],"strength":["1 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"LABORATORIOS AUROBINDO S.L.U.","status":{"state":"current","value":{"lifecycle":"history","marketed":false,"marketing_date":"2021-07-08","pack_status":"Anulado","pack_status_date":"2021-07-08"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"TZDIp6Z-VE2l-WxdHuK-cxr58-aXz7wd-gNehovWM15ZYu3knCiqtUuotZJwrzo-4L9WvY76Q6tLKwUJNyjM8Q","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08470006961650","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:717769","market":"ES","level":"presentation","gtin":"08470007177692","national_pack_code":null,"pack_level_published":true,"name":"NOVONORM 1 mg, COMPRIMIDOS, 90 comprimidos","substance":["REPAGLINIDA"],"strength":["1 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"NOVO NORDISK A/S","status":{"state":"current","value":{"lifecycle":"current","marketed":true,"marketing_date":"2011-07-14","pack_status":"Autorizado","pack_status_date":"1999-06-01"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"b_NPomkftDZBb0S6LFhOUwNLQP4O6w-OiJN8tciCq3qk7QVL9ZWy5igJX7ecdm0JBk3atIWFAgVa1slvNsbv7Q","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08470007177692","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:724863","market":"ES","level":"presentation","gtin":"08470007248637","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDA AUROVITAS 1 MG COMPRIMIDOS EFG 90 comprimidos","substance":["REPAGLINIDA"],"strength":["1 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"AUROVITAS SPAIN, S.A.U.","status":{"state":"current","value":{"lifecycle":"current","marketed":true,"marketing_date":"2019-08-28","pack_status":"Autorizado","pack_status_date":"2019-02-20"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"eTUGxmGViKBYIcJD6fOOH4lW9X6JTsnu94SswvtDz-lHtHHTeubgl3TEa8vERQbcTPyGzqO6xxtnO8wd25UBRg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08470007248637","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"es:presentation:cn:825430","market":"ES","level":"presentation","gtin":"08470008254309","national_pack_code":null,"pack_level_published":true,"name":"PRANDIN 1 mg, COMPRIMIDOS, 90 comprimidos","substance":["REPAGLINIDA"],"strength":["1 mg"],"form":["COMPRIMIDO"],"pack":["90 comprimidos"],"holder":"NOVO NORDISK A/S","status":{"state":"current","value":{"lifecycle":"current","marketed":false,"marketing_date":"2022-08-05","pack_status":"Autorizado","pack_status_date":"2002-03-25"}},"source_authority":"AEMPS","read_at":"2026-11-15T10:11:04Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"Aw6XQmCl2NVOFiFbBy3diRQEYq3M8z6vSYjBGOh47t5sM4j_3TJwyQtpjTSl9NCX2N8Hko0YeQuYsFOEWoGaAA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/es/08470008254309","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"fr:presentation:cip13:3400922227917","market":"FR","level":"presentation","gtin":"03400922227917","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDE ACCORD 1 mg, comprimé","substance":["RÉPAGLINIDE"],"strength":[],"form":["comprimé"],"pack":["plaquette(s) thermoformée(s) aluminium de 90 comprimé(s)"],"holder":"ACCORD HEALTHCARE (ESPAGNE)","status":{"state":"current","value":{"bdpm_status":null,"marketing":"Commercialisée","term":"Autorisation active"}},"source_authority":"ANSM","read_at":"2026-11-15T11:14:34Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"nIj05j5btR6W2mcWF33eP_K0Z_47Q-XTErOCw55Ky-Ha8k8_SHVOIYSJoIkQXIObynlPMmqHCh-UezQ-dCkqwg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/fr/03400922227917","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"fr:presentation:cip13:3400922228228","market":"FR","level":"presentation","gtin":"03400922228228","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDE ACCORD 1 mg, comprimé","substance":["RÉPAGLINIDE"],"strength":[],"form":["comprimé"],"pack":["plaquette(s) thermoformée(s) aluminium de 270 comprimé(s)"],"holder":"ACCORD HEALTHCARE (ESPAGNE)","status":{"state":"current","value":{"bdpm_status":null,"marketing":"Commercialisée","term":"Autorisation active"}},"source_authority":"ANSM","read_at":"2026-11-15T11:14:34Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"TthY7E66G8SazmUl4kjXTFgLD3LSqe6oUPzS6-kPcZkp0ybiaROrQh8TyumV1BMQA2SGWELJdYfWFG5ULBR-OQ","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/fr/03400922228228","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"fr:presentation:cip13:3400926644253","market":"FR","level":"presentation","gtin":"03400926644253","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDE KRKA 1 mg, comprimé","substance":["RÉPAGLINIDE"],"strength":[],"form":["comprimé"],"pack":["plaquette(s) thermoformée(s) polyamide aluminium PVC-Aluminium de 90 comprimé(s)"],"holder":"KRKA (SLOVENIE)","status":{"state":"current","value":{"bdpm_status":null,"marketing":"Commercialisée","term":"Autorisation active"}},"source_authority":"ANSM","read_at":"2026-11-15T11:14:34Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"SwFGEvXSgw6RntQyai-HPe507gFqMzxfvtMczZwvZI9wSLs6voPFAvafaa3qAYyNLf2sfI7LPK5MFhUD7EPvqg","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/fr/03400926644253","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}},{"record_id":"fr:presentation:cip13:3400926644314","market":"FR","level":"presentation","gtin":"03400926644314","national_pack_code":null,"pack_level_published":true,"name":"REPAGLINIDE KRKA 1 mg, comprimé","substance":["RÉPAGLINIDE"],"strength":[],"form":["comprimé"],"pack":["plaquette(s) thermoformée(s) polyamide aluminium PVC-Aluminium de 270 comprimé(s)"],"holder":"KRKA (SLOVENIE)","status":{"state":"current","value":{"bdpm_status":null,"marketing":"Commercialisée","term":"Autorisation active"}},"source_authority":"ANSM","read_at":"2026-11-15T11:14:34Z","signature":{"kid":"dosidal-record-1.9dbf5d53","sig":"xnfDcUr6bHRlufhznWCN764Y3-VYweaPMqAqkI0Hyc5hX5NpZ7RjlTCZBNc33zWXVOxCDet9rEBhoyn8cQ0RTA","alg":"ES256","canon":"JCS"},"page":"https://dosidal.ai/pack/fr/03400926644314","link":{"label":"same substance, strength and form","basis":["substance code (ATC) with strength and form"],"note":"A link shows how two records are related. It does not say one product can be used in place of another."}}],"total":200,"note":"A link shows how two records are related. It does not say one product can be used in place of another.","receipt":{"v":"1","id":"rco-dosidal:468edacf-22a9-41c8-8b0d-252357deecc5","seq":9815,"writer":"https://dosidal-api.ai","caller":"public","subject":"pl:presentation:89596","subject_type":"-","market":"-","rule_version":"1.0+1.0+open-read:related_records","cleared_at":"2026-11-16T04:10:19Z","answer_hash":"a6b472ee88942e1b2a7027eaa949c66b47978eb941bf7149daa4f50c01566303","prev_hash":"2c094ab78ce50c31fca7eb313762b1ec8a6bcba7a9fa7d175e36fdd5c999101a","hash":"6bf8da0f829057bb129f8aef0ab81015e0ffcb537823dc3b9309b986147c1bf4","kid":"dosidal-rco-1.98a18493","sig":"Ix5jSqLimmPubpCkX4nSE9K_ATGUq2HpJoZP4zUhdWP4ZhRYC1XQQSnwIzNhJVxLfdbmncHve7cFfqnI68j2xw"},"scope":"Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.","notice":"Artificial intelligence makes mistakes. Read the regulator.","region":"wus2"}